Burkholderia cepacia bacteremia: A prospective analysis of 33 episodes;Bacteriemias por burkholderia cepacia: Análisis prospectivo de 33 episodios

Revista Espanola de Quimioterapia

Volumn 24, Issue 4, 2011, Pages 209-212

  Pinilla, Maialen Ibarguren ^a   Cobos Trigueros, Nazaret ^a   Soriano, Álex ^a   Martínez, José Antonio ^a   Zboromyrska, Yuliya ^a   Almela, Manel ^a   Mensa, José ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antimicrobial susceptibility; Bacteraemia; Burkholderia cepacia; Outbreak; Outcome; Sporadic cases

Indexed keywords

COTRIMOXAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA CEPACIA INFECTION; CASE STUDY; CATHETER INFECTION; CLINICAL ARTICLE; DISEASE ACTIVITY; EPIDEMIC; GRAM NEGATIVE SEPSIS; HUMAN; IDIOPATHIC DISEASE; PROSPECTIVE STUDY; SPORADIC DISEASE; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; EPIDEMICS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84856029014     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A et al. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection 2010; 38: 187-94.
2. Souza AV, Moreira CR, Pasternak J, Hirata MDL, Saltini DA, Caetano VC et al. Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. J Med Microbiol 2004; 53: 999-1005.
3. Lo A, Cascio G, Bonora M, Zorzi A, Mortani E, Tessitore N et al. napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. Infect 2006; 64: 56-62.
4. Woods CW, Bressler AM, LiPuma JJ, Alexander BD, Clements DA, Weber DJ, et al. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin Infect Dis 2004; 38: 1243-50.
5. Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB et al. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a casecontrol study. Infect Control Hosp Epidemiol 2007; 28: 951-8.
6. Lu DC, Chang SC, Chen YC, Luh KT, Lee CY, Hsieh WC. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes. J Formos Med Assoc 1997; 96: 972-8.
7. Saika T, Kobayashi I, Hasegawa M, Nishida M. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates. J Infect Chemother 2002; 8: 341-4.
8. Avgeri SG, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents 2009; 33: 394-404.
9. Peeters E, Nelis HJ, Coenye T. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother 2009; 64: 801-9.
10. Álvarez-Lerma F, Maull E, Terradas R, Segura C, Planells I, Coll P et al. Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit. Critical Care 2008; 12: R10.